The use of restricted mean survival time to estimate treatment effect under model misspecification, a simulation study

Emily Alger, David S. Robertson, Abigail J. Burdon

The use of the non-parametric Restricted Mean Survival Time endpoint (RMST) has grown in popularity as trialists look to analyse time-to-event outcomes without the restrictions of…